Jeffrey P Koplan, Rafael Harpaz. Show Affiliations »
Abstract
Mesh： See more » Cost-Benefit AnalysisHerpes Zoster/prevention & controlHerpesvirus 3, Human/immunologyHerpesvirus Vaccines/economicsHerpesvirus Vaccines/therapeutic useHumansNeuralgia, Postherpetic/prevention & control
Substances： See more » Herpesvirus Vaccines
Year: 2006 PMID： 16954362 DOI： 10.7326/0003-4819-145-5-200609050-00012
Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391